David Lebwohl, EVP, Chief Medical Officer at Intellia Therapeutics, Inc. (NTLA), sold 11,903 shares at $9.21 ($110K) on 2026-01-05, disclosed to the SEC on 2026-01-07.
Seasonal sale ($110k) by EVP, Chief Medical Officer — this insider has traded NTLA in January in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| Filing → |
| NTLA | SELL | 2023-01-06 | $192K | — | Filing → |
| NTLA | SELL | 2022-03-03 | $236K | — | Filing → |
| NTLA | SELL | 2021-11-09 | $452K | — | Filing → |